First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - CANCER RESEARCH PAKISTAN

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: CANCER RESEARCH PAKISTAN, Hampden House Chalgrove, Oxford, Oxfordshire, OX44 7RW. The legal status is a Private Limited Company By Guarantee Without Share Capital, Use Of 'Limited' Exemption and the current status at the registry of companies is Dissolved. The company was incorporated on 17 October 2019.

The accounts next due date is 17 July 2021. There are no mortgages.

The above was based on public record information as at 27 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 12268097
Date Incorporated: 17 October 2019
Date Latest Accounts: Unknown
BUSINESS INFORMATION
Legal Form: Private Limited Company By Guarantee Without Share Capital, Use Of 'Limited' Exemption
Previous Names: None
Registered Number: 12268097
Annual Return: Unknown
Registered Office: Hampden House Chalgrove, Oxford, Oxfordshire, OX44 7RW
SIC Code and Operations: 86900
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

CANCER RESEARCH PAKISTAN

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 7 October 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
SC790866 CANCER RESEARCH SCOTLAND INSTITUTE LIMITED Active
01626049 CANCER RESEARCH TECHNOLOGY LIMITED Active
04325234 CANCER RESEARCH UK Active
07397668 CANCER RESEARCH UK PENSION TRUSTEE LIMITED Active
SC790865 CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd